Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ClearStream's balloon catheters

This article was originally published in Clinica

Executive Summary

Enniscorthy, Ireland-based ClearStream Technologies has received 510(k) approval from the US FDA for its percutaneous transluminal angioplasty balloon catheters. The catheters will be marketed in the US by Cordis, under the brand names Sleek and Savvy Long. The Sleek device is designed for use in infrapopliteal vessels, while the Savvy Long provides an over-the-wire alternative for both superficial femoral and infrapopliteal arteries. The approval covers the full range of the products' balloon sizes and will include the longest PTA balloons on the worldwide market: 40-220mm lengths for Sleek, and 120, 150 and 220mm lengths for Savvy Long. Both products are expected to launch in the US in the first half of 2008; the launch will be the first time these balloon lengths will be available in the country. Both catheters have already been launched outside the US, ClearStream CEO Andrew Jones told Clinica. They are marketed in Europe as Sleek and Savvy Long, but also under the brand names LitePAC and Bantam, respectively.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT046218

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel